ScholarIQanswers from OpenAlex

A Trial of Darbepoetin Alfa in Type 2 Diabetes and Chronic Kidney Disease

PaperCitations, authors & open-access status

A Trial of Darbepoetin Alfa in Type 2 Diabetes and Chronic Kidney Disease is a paper indexed in ScholarIQ from OpenAlex.

How many citations does A Trial of Darbepoetin Alfa in Type 2 Diabetes and Chronic Kidney Disease have?

ScholarIQcitation count

A Trial of Darbepoetin Alfa in Type 2 Diabetes and Chronic Kidney Disease has 2,088 citations in the OpenAlex counts ScholarIQ stores.

When was A Trial of Darbepoetin Alfa in Type 2 Diabetes and Chronic Kidney Disease published?

ScholarIQyear

A Trial of Darbepoetin Alfa in Type 2 Diabetes and Chronic Kidney Disease has 2009 year in the ScholarIQ index.

What is the open-access status of A Trial of Darbepoetin Alfa in Type 2 Diabetes and Chronic Kidney Disease?

ScholarIQoa status

A Trial of Darbepoetin Alfa in Type 2 Diabetes and Chronic Kidney Disease has bronze oa status in the ScholarIQ index.

What is the DOI of A Trial of Darbepoetin Alfa in Type 2 Diabetes and Chronic Kidney Disease?

ScholarIQdoi

The DOI for A Trial of Darbepoetin Alfa in Type 2 Diabetes and Chronic Kidney Disease is on the source record.

What is the PMID of A Trial of Darbepoetin Alfa in Type 2 Diabetes and Chronic Kidney Disease?

ScholarIQpmid

The PMID for A Trial of Darbepoetin Alfa in Type 2 Diabetes and Chronic Kidney Disease is on the source record.

What is the OpenAlex record for A Trial of Darbepoetin Alfa in Type 2 Diabetes and Chronic Kidney Disease?

ScholarIQopenalex

The OpenAlex for A Trial of Darbepoetin Alfa in Type 2 Diabetes and Chronic Kidney Disease is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial